BioNexus Gene Lab Corp. (BGLC) Net income 2018–2025
BioNexus Gene Lab Corp. (BGLC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$3.0MFY2025 · since FY2018: $26,454 → -$3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.0M | -86.7% |
| FY2024 | -$1.6M | +39.2% |
| FY2023 | -$2.6M | -638.6% |
| FY2022 | -$355,966 | -147.4% |
| FY2021 | $751,571 | -31.3% |
| FY2020 | $1.1M | +543.9% |
| FY2019 | -$246,469 | -1031.7% |
| FY2018 | $26,454 | — |
Source: SEC XBRL filings · For reference only · Not investment advice